Cytokinetics, Inc. (CYTK)
62.58
-0.86
(-1.35%)
USD |
NASDAQ |
Jan 16, 16:00
62.54
-0.04
(-0.06%)
Pre-Market: 20:00
Cytokinetics Market Cap: 7.651B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 112.50B |
| Molina Healthcare, Inc. | 9.838B |
| Jasper Therapeutics, Inc. | 42.82M |
| Fortrea Holdings, Inc. | 1.525B |
| Lifecore Biomedical, Inc. | 307.97M |
Market Cap Related Metrics
| PS Ratio | 85.39 |
| PEG Ratio | -0.5807 |
| Price | 62.58 |
| Earnings Yield | -10.08% |
| PEGY Ratio | -0.5807 |